InvestorsHub Logo
Followers 16
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: None

Saturday, 12/14/2019 10:42:11 AM

Saturday, December 14, 2019 10:42:11 AM

Post# of 731857
I’m going to offer my unsolicited opinions on this week’s news...

The company is preparing for commercialization. The data we have all seen (including them) supports approval of this vaccine with one to four regulatory agencies. They’re anticipating this. They’ve now hired a CFO. They’re lining up manufacturing. They’re preparing to move forward with commercialization. Remember the “work in parallel” guidance? This fits the bill.

Datalock will probably come in the next few weeks. Topline will probably be announced in the first quarter. Full data by ASCO. I expect approval by the fall.

This is a 400 million + dollar trial and, despite the delays unblinding due to survivorship, I think ultimately it will be successful. The company thinks so too and is making plans in parallel for success.

Cheers to a prosperous 2020. I’m sorry for the long suffering investors who’ve had to wait this long for success. I hope everyone can add more shares in this, the season of tax selling and see great value correction when data and approval are announced!

Photonic5
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News